Real-World Biomarker Testing and Treatment Patterns for Locally Advanced and Metastatic Non-Small Cell Lung Cancer in Canada

被引：0
作者：
Laforty, C. [1 ]
Tong, M. [1 ]
Sharma, A. [2 ]
Kim, Y. [3 ]
Devost, N. [3 ]
Qadeer, R. [3 ]
Navani, V. [4 ]
机构：
[1] IQVIA, Toronto, ON, Canada
[2] IQVIA, Ottawa, ON, Canada
[3] AstraZeneca Canada, Mississauga, ON, Canada
[4] Univ Calgary, Tom Baker Canc Ctr, Calgary, AB, Canada
来源：
JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 10期
关键词：
Locally Advanced and Metastatic NSCLC; Biomarker; Treatment Patterns;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP.12G.02
引用
收藏
页码：S656 / S657
页数：2
相关论文
共 50 条
[41]   Biomarker Testing for Guiding Precision Medicine for Patients With Non-Small Cell Lung Cancer [J].
Fox, Adam H. ;
Alexander, Mariam ;
Forcucci, Jessica A. ;
Silvestri, Gerard A. .
CHEST, 2024, 166 (05) :1239-1249
[42]   Treatment patterns for advanced non-small cell lung cancer in the US: A systematic review of observational studies [J].
Lee, Adam ;
Yuan, Yong ;
Eccles, Laura ;
Chitkara, Anushri ;
Dalen, Johan ;
Varol, Nebibe .
CANCER TREATMENT AND RESEARCH COMMUNICATIONS, 2022, 33
[43]   Osteopontin is a prognostic biomarker in non-small cell lung cancer [J].
Rud, Ane Kongsgaard ;
Boye, Kjetil ;
Oijordsbakken, Miriam ;
Lund-Iversen, Marius ;
Halvorsen, Ann Rita ;
Solberg, Steinar K. ;
Berge, Gisle ;
Helland, Aslaug ;
Brustugun, Odd Terje ;
Maelandsmo, Gunhild M. .
BMC CANCER, 2013, 13
[44]   Predictive Biomarker Testing for Programmed Cell Death 1 Inhibition in Non-Small Cell Lung Cancer [J].
Sheffield, Brandon S. ;
Geller, Georgia ;
Pleasance, Erin ;
Zachara-Szczakowski, Susanna ;
Milne, Katy ;
Kalloger, Steve E. ;
Zhao, Eric ;
Bidnur, Samir ;
Jones, Martin ;
Nelson, Brad H. ;
Yip, Stephen ;
Marra, Marco A. ;
Laskin, Janessa ;
Ho, Cheryl ;
Ionescu, Diana .
JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) :S199-S199
[45]   BIOMARKER PATTERN IN NEVER SMOKER PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) [J].
Santos, Edgardo S. ;
Ochoa, Roberto E. ;
Bisneto, Jose Villasboas ;
Gomez, Jorge E. ;
Danenberg, Kathleen ;
Raez, Luis E. .
JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) :S1111-S1112
[46]   Evaluation of Combined Biomarker of Response to Immunotherapy in Patients with Advanced Non-Small Cell Lung Cancer [J].
Ramdani, H. ;
Falk, M. ;
Schatz, S. ;
Heukamp, L. ;
Tiemann, M. ;
Wesseler, C. ;
Schuuring, E. ;
Groen, H. ;
Griesinger, F. .
JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) :S413-S414
[47]   Pulmonologists' Attitudes and Role in Precision Medicine Biomarker Testing for Non-Small Cell Lung Cancer [J].
Fox, Adam H. ;
Rudzinski, Mark A. ;
Nietert, Paul J. ;
Silvestri, Gerard A. .
CHEST, 2024, 166 (05) :1229-1238
[48]   Systemic therapy treatment patterns in patients with advanced non-small cell lung cancer (NSCLC): PIvOTAL study [J].
de Castro, J. ;
Tagliaferri, P. ;
de Lima, V. C. C. ;
Ng, S. ;
Thomas, M. ;
Arunachalam, A. ;
Cao, X. ;
Kothari, S. ;
Burke, T. ;
Myeong, H. ;
Grattan, A. ;
Lee, D. H. .
EUROPEAN JOURNAL OF CANCER CARE, 2017, 26 (06)
[49]   Pre- and on-treatment lactate dehydrogenase as a prognostic and predictive biomarker in advanced non-small cell lung cancer [J].
Tjokrowidjaja, Angelina ;
Lord, Sarah J. ;
John, Thomas ;
Lewis, Craig R. ;
Kok, Peey-Sei ;
Marschner, Ian C. ;
Lee, Chee K. .
CANCER, 2022, 128 (08) :1574-1583
[50]   A systematic literature review of real-world treatment outcomes of small cell lung cancer [J].
Stokes, Michael ;
Berfeld, Noami ;
Gayle, Alicia ;
Descoteaux, Andrew ;
Rohrmoser, Oscar ;
Franks, April .
MEDICINE, 2022, 101 (26) :E29783
12345